ArticleJTO clinical and research reports2023

Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC.

Brandon S Imber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.